CN209678849U - A functional multilayer hemostatic antibacterial dressing - Google Patents
A functional multilayer hemostatic antibacterial dressing Download PDFInfo
- Publication number
- CN209678849U CN209678849U CN201821405192.4U CN201821405192U CN209678849U CN 209678849 U CN209678849 U CN 209678849U CN 201821405192 U CN201821405192 U CN 201821405192U CN 209678849 U CN209678849 U CN 209678849U
- Authority
- CN
- China
- Prior art keywords
- layer
- hemostatic
- wound
- antibacterial
- antibacterial dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 29
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 28
- 239000000835 fiber Substances 0.000 claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 229910010272 inorganic material Inorganic materials 0.000 claims abstract description 17
- 239000011147 inorganic material Substances 0.000 claims abstract description 17
- 238000010521 absorption reaction Methods 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 16
- 230000004888 barrier function Effects 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000002121 nanofiber Substances 0.000 claims abstract description 11
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 7
- 238000001266 bandaging Methods 0.000 claims abstract description 6
- 229920005615 natural polymer Polymers 0.000 claims abstract description 6
- 239000011347 resin Substances 0.000 claims abstract description 5
- 229920005989 resin Polymers 0.000 claims abstract description 5
- -1 polypropylene Polymers 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 4
- 108010022355 Fibroins Proteins 0.000 claims description 4
- 239000004677 Nylon Substances 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 229920000297 Rayon Polymers 0.000 claims description 4
- 238000001467 acupuncture Methods 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 229920001778 nylon Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052621 halloysite Inorganic materials 0.000 claims description 3
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 2
- 239000002861 polymer material Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 abstract description 46
- 206010052428 Wound Diseases 0.000 abstract description 45
- 230000029663 wound healing Effects 0.000 abstract description 10
- 230000023597 hemostasis Effects 0.000 abstract description 9
- 239000002390 adhesive tape Substances 0.000 abstract description 6
- 206010072170 Skin wound Diseases 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 210000000416 exudates and transudate Anatomy 0.000 description 9
- 229940124350 antibacterial drug Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000035699 permeability Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- FUBFWTUFPGFHOJ-UHFFFAOYSA-N 2-nitrofuran Chemical class [O-][N+](=O)C1=CC=CO1 FUBFWTUFPGFHOJ-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 244000307697 Agrimonia eupatoria Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- 241001435059 Artemisia argyi Species 0.000 description 2
- 241001313857 Bletilla striata Species 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 2
- 241000123069 Ocyurus chrysurus Species 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 108010040201 Polymyxins Proteins 0.000 description 2
- 102000007327 Protamines Human genes 0.000 description 2
- 108010007568 Protamines Proteins 0.000 description 2
- 229930189077 Rifamycin Natural products 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000003470 adrenal cortex hormone Substances 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 2
- 229960003375 aminomethylbenzoic acid Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 229940019700 blood coagulation factors Drugs 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 235000000125 common agrimony Nutrition 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960000308 fosfomycin Drugs 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000001861 immunosuppressant effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 229940041153 polymyxins Drugs 0.000 description 2
- 229940048914 protamine Drugs 0.000 description 2
- 150000007660 quinolones Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940081192 rifamycins Drugs 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 229940040944 tetracyclines Drugs 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- 239000009306 yunnan baiyao Substances 0.000 description 2
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3s)-3,6-diamino-n-[[(2s,5s,8e,11s,15s)-15-amino-11-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3s)-3,6-diamino-n-[[(2s,5s,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010063746 Accidental death Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108010065839 Capreomycin Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229960004602 capreomycin Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- BTVYFIMKUHNOBZ-QXMMDKDBSA-N rifamycin s Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)\C=C/OC1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-QXMMDKDBSA-N 0.000 description 1
- 238000001350 scanning transmission electron microscopy Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本实用新型公开了一种功能性多层止血抗菌敷料,它为四层结构,按与创面接触由内而外,依次包括创面接触层,液体吸收层,阻隔层和包扎固定层,各层之间以胶粘或针刺法复合;创面接触层以直径为200~400 nm的可降解天然高分子纳米纤维为基材,载药无机材料分布在纳米纤维中;液体吸收层为吸水性纤维与高吸水性树脂构成的非织造材料层;阻隔层为疏水性纤维构成的非织造材料层;包扎固定层为低敏性弹性医用胶布层,呈条带状。由于创面接触层为包含无机材料的纳米纤维结构,载药释放后快速到达皮肤创面,实现止血、抗菌、以及促进创面愈合的作用。本实用新型还具有生物相容性好,物理机械性能优良,制备工艺简单,有利于产业化生产的特点。
The utility model discloses a functional multi-layer hemostatic and antibacterial dressing, which is a four-layer structure, which sequentially includes a wound contact layer, a liquid absorption layer, a barrier layer and a bandaging and fixing layer according to the contact with the wound surface from the inside to the outside. The wound contact layer is based on degradable natural polymer nanofibers with a diameter of 200-400 nm, and the drug-loaded inorganic materials are distributed in the nanofibers; the liquid absorption layer is made of water-absorbing fibers and The non-woven material layer is composed of superabsorbent resin; the barrier layer is a non-woven material layer composed of hydrophobic fibers; the wrapping and fixing layer is a low-sensitivity elastic medical adhesive tape layer in strip shape. Since the wound surface contact layer is a nanofibrous structure containing inorganic materials, the loaded drug can quickly reach the skin wound surface after being released, so as to realize the effects of hemostasis, antibacterial, and wound healing promotion. The utility model also has the characteristics of good biocompatibility, excellent physical and mechanical properties, simple preparation process and favorable industrial production.
Description
技术领域technical field
本实用新型属于医用敷料领域,具体而言,涉及一种功能性多层止血抗菌敷料,用于皮肤创面的快速有效止血、抗菌及加速伤口愈合。The utility model belongs to the field of medical dressings, in particular to a functional multilayer hemostatic and antibacterial dressing, which is used for fast and effective hemostasis, antibacterial and accelerated wound healing of skin wounds.
背景技术Background technique
伤口的种类繁多,形成原因各不相同,生活中常见的伤口包括机械损伤,烧伤等原因造成的急性创伤。失血和细菌感染是创伤死亡的首要因素,若能及时有效地止血、抗菌,对挽救伤患的性命具有重要的意义。There are many types of wounds with different causes. The common wounds in daily life include acute trauma caused by mechanical damage, burns and other reasons. Hemorrhage and bacterial infection are the primary factors of traumatic death, and timely and effective hemostasis and antibacterial treatment are of great significance to save the lives of injured patients.
医用敷料作为伤口处的覆盖物,在伤口愈合过程中,可以替代受损的皮肤起到暂时性屏障作用,避免和控制伤口感染,提供有利于创面愈合的环境。现在市场上使用的医用敷料仍存在很多不足,如吸收创面渗液能力有限,在使用时无法保持创面愈合所需的湿润环境,延迟创面愈合,需要多次更换,而且容易粘连伤口,在使用时易造成二次伤害等;同时,人们更希望缩短伤口康复时间。因此,在世界医疗卫生领域多功能医用敷料的需求将会不断增加。As a covering for wounds, medical dressings can replace damaged skin to act as a temporary barrier during wound healing, avoid and control wound infection, and provide an environment conducive to wound healing. The medical dressings used in the market still have many deficiencies, such as limited ability to absorb wound exudate, cannot maintain the moist environment required for wound healing during use, delay wound healing, need to be replaced many times, and are easy to adhere to the wound. It is easy to cause secondary injury, etc.; at the same time, people hope to shorten the wound recovery time. Therefore, the demand for multifunctional medical dressings in the world medical and health field will continue to increase.
发明内容Contents of the invention
本实用新型针对现有技术存在的缺陷,提供一种生物相容性好,物理机械性能优良的具有止血抗菌作用,并可加速皮肤创面愈合的多功能医用敷料。Aiming at the defects of the prior art, the utility model provides a multifunctional medical dressing with good biocompatibility, excellent physical and mechanical properties, hemostatic and antibacterial effects, and accelerated skin wound healing.
为达到上述发明目的,本实用新型采用的技术方案是提供一种功能性多层止血抗菌敷料,它为四层结构,按与创面接触由内而外,依次包括创面接触层,液体吸收层,阻隔层和包扎固定层,各层之间以胶粘或针刺法复合;所述的创面接触层以直径为200~400 nm的可降解天然高分子纳米纤维为基材,载药无机材料分布在纳米纤维中;所述的液体吸收层为吸水性纤维与高吸水性树脂构成的非织造材料层;所述的阻隔层为疏水性纤维构成的非织造材料层,阻隔层的尺寸大于层创面接触层;所述的包扎固定层为低敏性弹性医用胶布层,呈条带状。In order to achieve the above-mentioned purpose of the invention, the technical solution adopted by the utility model is to provide a functional multilayer hemostatic antibacterial dressing, which is a four-layer structure, which includes a wound contact layer, a liquid absorption layer, and a wound contact layer from the inside to the outside according to the contact with the wound surface. The barrier layer and the dressing and fixing layer are compounded by adhesive or acupuncture; the wound contact layer is based on degradable natural polymer nanofibers with a diameter of 200-400 nm, and the drug-loaded inorganic materials are distributed In nanofibers; the liquid-absorbing layer is a non-woven material layer composed of water-absorbent fibers and superabsorbent resin; the barrier layer is a non-woven material layer composed of hydrophobic fibers, and the size of the barrier layer is larger than that of the wound surface The contact layer; the bandaging and fixing layer is a low-sensitivity elastic medical adhesive tape layer in the shape of a strip.
本实用新型采用的可降解天然高分子纳米纤维包括丝素蛋白、壳聚糖;无机材料包括埃洛石、高岭土、蒙脱土;按质量百分比,载药无机材料为可降解天然高分子材料的1~5%。有机材料所载的药物包括止血类和抗菌类药物;止血类药物包括维生素K、6氨基己酸、对羧基苄胺、止血环酸、鱼精蛋白、肾上腺皮质激素、免疫抑制剂环磷酰胺、云南白药、三七、止血灵、仙鹤草、白芨、紫草、茜草、白茅根、艾叶、紫珠、凝血因子中的一种或几种;抗菌类药物包括青霉素类、头孢霉素类、氨曲南、万古霉素、磷霉素、利福霉素类、喹诺酮类、氨基糖苷类、多粘菌素类、大环内酯类、四环素类、氯霉素类、林可霉素类、硝基呋喃类、磺胺类、卷曲霉素中的一种或几种。The degradable natural macromolecule nanofibers adopted in the utility model include silk fibroin and chitosan; 1 to 5%. The drugs contained in organic materials include hemostatic and antibacterial drugs; hemostatic drugs include vitamin K, 6-aminocaproic acid, p-carboxybenzylamine, tranexamic acid, protamine, adrenocortical hormone, immunosuppressant cyclophosphamide, One or more of Yunnan Baiyao, Panax notoginseng, Zhixueling, Agrimony, Bletilla striata, Comfrey, Rubia, Imperatae, Artemisia argyi, Zizhu, blood coagulation factors; antibacterial drugs include penicillins, cephalosporins, ammonia Qunan, vancomycin, fosfomycin, rifamycins, quinolones, aminoglycosides, polymyxins, macrolides, tetracyclines, chloramphenicol, lincomycins, One or more of nitrofurans, sulfonamides, and capreomycin.
所采用的吸水性纤维包括粘胶纤维、脱脂棉纤维。The absorbent fibers used include viscose fibers and absorbent cotton fibers.
所采用的疏水性纤维包括丙纶、涤纶、锦纶。The hydrophobic fibers used include polypropylene, polyester, and nylon.
本实用新型提供的多功能医用敷料兼具抗菌、止血、透气、吸收伤口渗出液,促进伤口愈合及隔离伤口与外界病菌的作用,其原理是:创面接触层采用的是纳米纤维结构,并结合无机材料载药系统,给药时间更长,药物释放率更高。创面接触层直接覆盖在创面的表面,止血、抗菌药物与止血性无机材料的结合不仅能够实现快速止血和杀菌,还能达到延长给药时间,增大药物缓释利用率的效果。液体吸收层主要是由无毒、对人体无刺激性的粘胶纤维、脱脂棉等吸水性较好的纤维与高吸水性树脂构成的非织造材料构成,具有高达自身100~1000倍的吸水量,可快速吸收血液中的水分及伤口渗出液。阻隔层主要是由丙纶、涤纶、锦纶等疏水性纤维构成的非织造材料,可以起到防止伤口渗出液外漏而浸渍周围皮肤的作用,且可以阻止外界病菌微生物入侵创面,预防感染。包扎固定层为透气性佳,粘性适中的低敏性弹性医用胶布,为条带状,胶布数量以适宜敷料大小为选择标准。包扎固定层起固定敷料,避免脱落,更好的保护创面的作用。The multifunctional medical dressing provided by the utility model has the functions of antibacterial, hemostatic, breathable, and absorbing wound exudate, promoting wound healing and isolating the wound from external germs. Combined with the inorganic material drug-loading system, the administration time is longer and the drug release rate is higher. The wound contact layer directly covers the surface of the wound. The combination of hemostasis, antibacterial drugs and hemostatic inorganic materials can not only achieve rapid hemostasis and sterilization, but also prolong the administration time and increase the utilization rate of drug sustained release. The liquid absorption layer is mainly composed of non-woven materials composed of non-toxic and non-irritating viscose fiber, absorbent cotton and other fibers with good water absorption and superabsorbent resin, which has a water absorption capacity of 100 to 1000 times its own. It can quickly absorb water in blood and wound exudate. The barrier layer is mainly non-woven materials composed of polypropylene, polyester, nylon and other hydrophobic fibers, which can prevent wound exudate from leaking and impregnating the surrounding skin, and can prevent external germs and microorganisms from invading the wound and preventing infection. The bandaging and fixing layer is a low-sensitivity elastic medical adhesive tape with good air permeability and moderate viscosity, which is strip-shaped, and the number of adhesive tapes is selected based on the appropriate dressing size. The bandaging and fixing layer can fix the dressing, avoid falling off, and better protect the wound surface.
本实用新型与现有技术相比,具有以下有益效果:Compared with the prior art, the utility model has the following beneficial effects:
1. 不粘伤口:本实用新型的创面接触层为纳米纤维层,具有高孔隙率,有利于细胞呼吸,透气性好,可促进组织修复。1. Non-stick wound: The wound contact layer of this utility model is a nanofiber layer with high porosity, which is beneficial to cell respiration, has good air permeability, and can promote tissue repair.
2.吸液率高:采用高吸水材料可快速吸收伤口渗出液且不外流,还能够维持创面的湿润环境,有利于伤口恢复。2. High liquid absorption rate: the use of high water absorption materials can quickly absorb wound exudate without leakage, and can also maintain a moist environment on the wound surface, which is conducive to wound recovery.
3.有效抗菌:采用天然抗菌材料壳聚糖及抗菌药物与无机材料的结合,可提高药物缓释效率,增长药物缓释时间,实现有效的抑菌杀菌作用。3. Effective antibacterial: The natural antibacterial material chitosan and the combination of antibacterial drugs and inorganic materials can improve the drug slow-release efficiency, prolong the drug slow-release time, and achieve effective antibacterial and bactericidal effects.
4.快速止血:创面接触层中的无机材料及其负载的止血药物具有较强的止血性能,液体吸收层通过快速吸收伤口渗出液及水分,促进血液凝固。4. Rapid hemostasis: The inorganic material in the wound contact layer and the hemostatic drug loaded therein have strong hemostatic properties, and the liquid-absorbing layer promotes blood coagulation by rapidly absorbing wound exudate and moisture.
5.防漏阻菌:采用阻隔层可以起到防止渗出液外漏以及阻隔外部细菌入侵的作用。5. Anti-leakage and anti-bacteria: The use of a barrier layer can prevent the leakage of exudate and block the invasion of external bacteria.
6.环保可降解:不需要多次更换敷料,节省资源,且所选的有机原料均为可降解材料,可减轻对环境的污染。6. Environmentally friendly and degradable: no need to change dressings many times, saving resources, and the selected organic raw materials are all degradable materials, which can reduce environmental pollution.
附图说明Description of drawings
图1是本实用新型实施例提供的一种功能性多层止血抗菌敷料的结构示意图。Fig. 1 is a schematic structural view of a functional multilayer hemostatic antibacterial dressing provided by an embodiment of the present invention.
其中,1为创面接触层,2为液体吸收层,3为阻隔层,4为包扎固定层。Wherein, 1 is a wound contact layer, 2 is a liquid absorbing layer, 3 is a barrier layer, and 4 is a dressing and fixing layer.
具体实施方式Detailed ways
下面结合附图和实施例对本实用新型技术方案作进一步的阐述。The technical solution of the utility model will be further elaborated below in conjunction with the accompanying drawings and embodiments.
实施例1Example 1
参见附图1,为本实施例提供的一种功能性多层止血抗菌敷料的结构示意图。它为四层结构,按与创面接触由内而外,依次包括创面接触层1,液体吸收层2,阻隔层3和包扎固定层4,各层之间以胶粘或针刺法复合。Referring to Figure 1, it is a schematic structural diagram of a functional multi-layer hemostatic antibacterial dressing provided in this embodiment. It has a four-layer structure, which includes a wound contact layer 1, a liquid absorbing layer 2, a barrier layer 3 and a bandaging and fixing layer 4 in order from the inside to the outside according to the contact with the wound surface, and the layers are compounded by gluing or acupuncture.
创面接触层:它是与创面直接接触的第一层,在本实施例中,将维生素K止血药物和青霉素类抗菌药物采用静电吸附的方法加载到0.15 g无机材料埃洛石的外表面和内部,将2.6的丝素蛋白干燥膜溶于17.4 g的甲酸中,制成质量分数为13%的丝素蛋白溶液,将0.6g的壳聚糖溶于20 mL的乙酸中,制成3%的壳聚糖溶液,将上述三种原料混合后的混合液采用静电纺丝法制备成纳米纤维膜,得到具有止血、抗菌、吸湿、透气性能的创面接触层。Wound contact layer: it is the first layer that is in direct contact with the wound. In this example, vitamin K hemostatic drugs and penicillin antibacterial drugs were loaded onto the outer surface and interior of 0.15 g of the inorganic material halloysite by electrostatic adsorption. , 2.6 g of silk fibroin dry film was dissolved in 17.4 g of formic acid to make a silk fibroin solution with a mass fraction of 13%, and 0.6 g of chitosan was dissolved in 20 mL of acetic acid to make a 3% Chitosan solution, the mixture solution after mixing the above three raw materials is prepared into a nanofiber film by an electrospinning method, and a wound surface contact layer with hemostatic, antibacterial, moisture absorption and air permeability properties is obtained.
对本实施例的功能性多层止血抗菌敷料的创面接触层进行扫描电镜和透射电镜检测,从透射电镜图可以看到,载药无机材料已复合到电纺纤维中;由扫描电镜图可以看到,纳米纤维具有很高的比表面积,因此具有吸收性好的特点,装载止血药物的无机材料能有效的提高伤口的止血速度,当创面细菌接触到敷料时,装载于无机材料中的抗菌药物的释放可有效抑菌杀菌。一般采用的载药无机材料为可降解天然高分子材料的1~5%,无机材料包括埃洛石、高岭土、蒙脱土。可采用的止血类药物包括维生素K、6氨基己酸、对羧基苄胺、止血环酸、鱼精蛋白、肾上腺皮质激素、免疫抑制剂环磷酰胺、云南白药、三七、止血灵、仙鹤草、白芨、紫草、茜草、白茅根、艾叶、紫珠、凝血因子中的一种或几种;采用的抗菌类药物包括青霉素类、头孢霉素类、氨曲南、万古霉素、磷霉素、利福霉素类、喹诺酮类、氨基糖苷类、多粘菌素类、大环内酯类、四环素类、氯霉素类、林可霉素类、硝基呋喃类、磺胺类、卷曲霉素中的一种或几种。The wound contact layer of the functional multilayer hemostatic and antibacterial dressing of this embodiment is detected by scanning electron microscopy and transmission electron microscopy. It can be seen from the transmission electron microscopy that the drug-loaded inorganic material has been compounded into the electrospun fiber; it can be seen from the scanning electron microscopy , nanofibers have a high specific surface area, so they have the characteristics of good absorption. Inorganic materials loaded with hemostatic drugs can effectively improve the speed of wound hemostasis. When wound bacteria contact the dressing, the antibacterial drugs loaded in the inorganic materials The release can effectively inhibit and kill bacteria. Generally, the drug-loaded inorganic material used is 1-5% of the degradable natural polymer material, and the inorganic material includes halloysite, kaolin, and montmorillonite. The hemostatic drugs that can be used include vitamin K, 6-aminocaproic acid, p-carboxybenzylamine, tranexamic acid, protamine, adrenocortical hormone, immunosuppressant cyclophosphamide, Yunnan Baiyao, Panax notoginseng, Zhixueling, Agrimony , Bletilla striata, Comfrey, Rubia, Imperatae, Artemisia argyi, Purple Pearl, blood coagulation factor or one or more; the antibacterial drugs used include penicillins, cephalosporins, aztreonam, vancomycin, fosfomycin rifamycins, quinolones, aminoglycosides, polymyxins, macrolides, tetracyclines, chloramphenicols, lincomycins, nitrofurans, sulfonamides, curly One or more of the mycins.
液体吸收层:采用粘胶纤维或脱脂棉等吸水性较好的纤维与高达自身100~1000倍吸水量的高吸水性树脂构成的非织造材料制作,伤口渗出液及血液中的水分被快速吸收,促进血液凝固,更加有利于止血目的的达成,吸液后的材料又可以为创面提供湿润的环境,有利于伤口的愈合。Liquid absorption layer: It is made of non-woven materials composed of viscose fiber or absorbent cotton and other fibers with good water absorption and super absorbent resin with a water absorption capacity of 100 to 1000 times its own. The water in the wound exudate and blood is quickly absorbed , to promote blood coagulation, which is more conducive to the achievement of hemostasis, and the material after absorbing liquid can provide a moist environment for the wound surface, which is conducive to wound healing.
阻隔层:采用透气而不透水的丙纶、涤纶、锦纶等疏水性纤维构成的非织造材料作为最外层阻隔层,防止伤口渗出液渗出,并阻隔外界病菌的侵入,其尺寸大于止血抗菌层。Barrier layer: non-woven material composed of breathable and impermeable polypropylene, polyester, nylon and other hydrophobic fibers is used as the outermost barrier layer to prevent wound exudate from seeping out and block the invasion of external germs. Its size is larger than that of hemostasis and antibacterial Floor.
包扎固定层:采用透气性佳,粘性适中的低敏性弹性医用胶布,为条带状,胶布数量以适宜敷料大小为选择标准,粘贴在未受创部位,起到固定敷料,避免脱落,可以更好的保护创面。Wrapping and fixing layer: Use low-sensitivity elastic medical adhesive tape with good air permeability and moderate viscosity, which is in the shape of a strip. The number of adhesive tapes is selected based on the appropriate dressing size. Better protect the wound surface.
将以上创面接触层,液体吸收层,阻隔层和包扎固定层通过胶粘或针刺法进行复合,并按照伤口尺寸与形状进行缝合裁剪,制成具有止血、抗菌、高吸液率,透气防粘、促进伤口愈合等作用的多功能止血抗菌敷料。The above wound contact layer, liquid absorption layer, barrier layer and bandage fixation layer are combined by adhesive or acupuncture, and are sutured and cut according to the size and shape of the wound to make a hemostatic, antibacterial, high liquid absorption rate, breathable and waterproof A multi-functional hemostatic and antibacterial dressing that sticks and promotes wound healing.
本实用新型提供的敷料结构简单,相应地制作工艺流程简单,适合产业化生产。The dressing provided by the utility model has a simple structure, a correspondingly simple manufacturing process, and is suitable for industrialized production.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821405192.4U CN209678849U (en) | 2018-08-29 | 2018-08-29 | A functional multilayer hemostatic antibacterial dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821405192.4U CN209678849U (en) | 2018-08-29 | 2018-08-29 | A functional multilayer hemostatic antibacterial dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209678849U true CN209678849U (en) | 2019-11-26 |
Family
ID=68593921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201821405192.4U Active CN209678849U (en) | 2018-08-29 | 2018-08-29 | A functional multilayer hemostatic antibacterial dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209678849U (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111481733A (en) * | 2020-04-22 | 2020-08-04 | 卢丽菊 | Biological medicine wound surface dressing |
| CN111616865A (en) * | 2020-06-23 | 2020-09-04 | 振德医疗用品股份有限公司 | A medical wound dressing for keeping the wound clean and dry |
| CN111686295A (en) * | 2020-06-24 | 2020-09-22 | 重庆理工大学 | Seepage self-adjusting composite dressing and preparation method thereof |
| CN112472416A (en) * | 2020-11-24 | 2021-03-12 | 天长市康特美防护用品有限公司 | Disposable blood-sucking armpit pad |
| CN117065075A (en) * | 2023-07-25 | 2023-11-17 | 天津工业大学 | Nanofiber antibacterial dressing and preparation method thereof |
-
2018
- 2018-08-29 CN CN201821405192.4U patent/CN209678849U/en active Active
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111481733A (en) * | 2020-04-22 | 2020-08-04 | 卢丽菊 | Biological medicine wound surface dressing |
| CN111481733B (en) * | 2020-04-22 | 2022-04-26 | 欣乐加生物科技温州有限公司 | Biological medicine wound surface dressing |
| CN111616865A (en) * | 2020-06-23 | 2020-09-04 | 振德医疗用品股份有限公司 | A medical wound dressing for keeping the wound clean and dry |
| CN111686295A (en) * | 2020-06-24 | 2020-09-22 | 重庆理工大学 | Seepage self-adjusting composite dressing and preparation method thereof |
| CN112472416A (en) * | 2020-11-24 | 2021-03-12 | 天长市康特美防护用品有限公司 | Disposable blood-sucking armpit pad |
| CN117065075A (en) * | 2023-07-25 | 2023-11-17 | 天津工业大学 | Nanofiber antibacterial dressing and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN209678849U (en) | A functional multilayer hemostatic antibacterial dressing | |
| CN102600018B (en) | Medical dressing with cooling function and wound healing prompting function and preparation method of medical dressing | |
| CN111228040B (en) | Absorbable anti-adhesion dressing and preparation method thereof | |
| Daunton et al. | A history of materials and practices for wound management | |
| CN104491914B (en) | A kind of porous pluralgel-nanofiber oxygen flow dressing and preparation method thereof | |
| EP3206725B1 (en) | "device for wound dressing" | |
| CN107454851A (en) | Hemostatic composition and hemostatic device (variants) | |
| CN104189942A (en) | Antibacterial wound dressing and preparation method thereof | |
| CN204931986U (en) | A kind of high-hygroscopicity antibacterial anti-sticking medical dressing | |
| CN102552964B (en) | Nano silver chitosan composite antibacterial composition, adhesive bandage and preparation method of adhesive bandage | |
| CN201333128Y (en) | Heath care adhesive bandage | |
| CN104383585B (en) | A kind of three-dimensional manometer composite adhesive bandage and preparation and application thereof | |
| CN201676083U (en) | Active silver ion antiseptic dressing for curing burns, scalds and wounds | |
| RU2578458C2 (en) | Multilayer wound dressing with multiple function nanomembranes and related products | |
| CN202761768U (en) | Medical dressing with functions of cooling and promoting wound healing | |
| CN109825955B (en) | Antibacterial and anti-allergic paper diaper for adults and preparation method thereof | |
| CN105664226A (en) | Medical composite dressing and preparation method thereof | |
| CN202960940U (en) | Surgical anti-adhesive absorbent gauze | |
| CN109289078B (en) | A long-acting antibacterial band-aid | |
| RU100724U1 (en) | ATRAUMATIC BANDING AGENT WITH NANOPARTICLES OF ASEPTICA SILVER | |
| CN214679180U (en) | Functional dressing with alginate | |
| CN211300666U (en) | a band-aid | |
| CN201578446U (en) | Alginate foam dressing | |
| CN205729616U (en) | Composite nano fiber medical dressing | |
| CN104001220A (en) | Novel skin regeneration material and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |